QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY

被引：0
|
作者：
Mulder, Midas [1 ,2 ]
Murad, Sarwa Darwish [2 ,3 ]
Busschbach, Jan [4 ]
Verhey, Elke [3 ]
de Jong, Koert [5 ]
van den Berg, Aad A. P. [6 ]
van Hoek, Bart [7 ]
Alwayn, Ian [8 ]
Erler, Nicole [9 ]
Polak, Wojciech [2 ,10 ]
de Winter, Brenda [1 ]
den Hoed, Caroline [2 ,3 ]
Metselaar, Herold [2 ,3 ]
机构：
[1] Univ Med Ctr Rotterdam, Dept Hosp Pharm, Erasmus MC, Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC Transplantat Inst, Erasmus MC, Rotterdam, Netherlands
[3] Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Erasmus MC, Rotterdam, Netherlands
[4] Univ Med Ctr Rotterdam, Sect Med Psychol & Psychotherapy, Dept Psychiat, Erasmus MC, Rotterdam, Netherlands
[5] Univ Med Ctr Groningen, Dept Surg, UMCG, Groningen, Netherlands
[6] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, UMCG, Groningen, Netherlands
[7] Leiden Univ, Med Ctr, LUMC, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, LUMC, Dept Surg, Leiden, Netherlands
[9] Univ Med Ctr Rotterdam, Dept Biostat, Erasmus MC, Rotterdam, Netherlands
[10] Univ Med Ctr Rotterdam, Dept Surg, Erasmus MC, Rotterdam, Netherlands
来源：
TRANSPLANT INTERNATIONAL | 2021年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OP336
引用
收藏
页码：169 / 170
页数：2
相关论文
共 50 条
  • [1] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
  • [2] EFFICACY AND SAFETY OF EVEROLIMUS IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS: RESULTS OF A MULTI-CENTER, RANDOMIZED, OPEN-LABEL CONVERSION STUDY
    Rostaing, Lionel
    Nevens, Frederik
    De Simone, Paolo
    Metselaar, Herold J.
    Sterneck, Martina R.
    Giostra, Emiliano
    Varo, Evaristo
    Dumortier, Jerome
    HEPATOLOGY, 2008, 48 (04) : 337A - 337A
  • [3] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
    Fischer, L.
    Kaiser, G. M.
    Huang, M. A.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Klintmalm, G.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J. M.
    LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
  • [4] Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.
    Saito, K.
    Uchida, K.
    Takahara, S.
    Yoshimura, N.
    Teraoka, S.
    Cornu-Artis, C.
    Kobayashi, E.
    Takahashi, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 314 - 314
  • [5] Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial.
    Saliba, F.
    Brown, R. S., Jr.
    Metselaar, H.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    LIVER TRANSPLANTATION, 2013, 19 : S100 - S101
  • [6] Impact on Wound Healing Events After Early Conversion to Everolimus in De Novo Renal Transplant Recipients: 24-Month Results from the Randomized ELEVATE Study.
    Nashan, B.
    van der Giet, M.
    Holdaas, H.
    Zeier, M.
    Pascual, J.
    Avihingsanon, Y.
    Lopez, P.
    Aguilar-Sanchez, J.
    Kochuparampil, J.
    Wang, Z.
    Cruzado, J.
    De Fijter, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 534 - 534
  • [7] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
  • [8] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [9] SINGLE CENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED, CROSS OVER STUDY TO EVALUATE THE PHARMACOKINETIC AND BIOAVAILABILITY OF ENVARSUS® IN COMPARISON TO ADVAGRAF® IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Herden, U.
    Sterneck, M.
    Li, J.
    Achilles, E.
    Buchholz, B.
    Fischer, L.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 19 - 19
  • [10] Cardiovascular Events with De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Potena, L.
    Schultz, U.
    Bara, C.
    Arizon, J. M.
    Dong, G.
    Lopez, P.
    Epailly, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S26 - S26
12345